DiaMedica Therapeutics Inc.
DMAC· Nasdaq
DMACDiaMedica Therapeutics Inc.
Filed May 13, 2020 · 10-Q · 43 days after period end · 0001437749-20-010599
| Metric | Q1 2020 | Q1 2019 | Q1 2018 |
|---|---|---|---|
| Net Income | -$2.43M | -$3.25M | -$650.00K |
| EPS Diluted | -$0.19 | -$0.27 | -$0.10 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
DiaMedica Therapeutics Inc. · CIK 1401040 · Engraved from SEC EDGAR
ended Mar 31, 2020 · filed May 13, 2020 · 43 d after period end
